Orchid Pharma Limited (ORCHPHARMA) - Total Assets

Latest as of March 2026: Rs19.11 Billion INR ≈ $206.66 Million USD

Based on the latest financial reports, Orchid Pharma Limited (ORCHPHARMA) holds total assets worth Rs19.11 Billion INR (≈ $206.66 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore ORCHPHARMA debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Orchid Pharma Limited - Total Assets Trend (2004–2026)

This chart illustrates how Orchid Pharma Limited's total assets have evolved over time, based on quarterly financial data. See Orchid Pharma Limited (ORCHPHARMA) net assets for net asset value and shareholders' equity analysis.

Orchid Pharma Limited - Asset Composition Analysis

Current Asset Composition (March 2026)

Orchid Pharma Limited's total assets of Rs19.11 Billion consist of 35.8% current assets and 64.2% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	0.4%
Accounts Receivable	Rs2.64 Billion	13.8%
Inventory	Rs2.56 Billion	13.4%
Property, Plant & Equipment	Rs0.00	0.0%
Intangible Assets	Rs736.76 Million	3.9%
Goodwill	Rs0.00	0.0%

Asset Composition Trend (2004–2026)

This chart illustrates how Orchid Pharma Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Orchid Pharma Limited market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Orchid Pharma Limited's current assets represent 35.8% of total assets in 2026, a decrease from 36.8% in 2004.
Cash Position: Cash and equivalents constituted 0.4% of total assets in 2026, down from 0.9% in 2004.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 2.0% in 2004.
Asset Diversification: The largest asset category is accounts receivable at 13.8% of total assets.

Orchid Pharma Limited Competitors by Total Assets

Key competitors of Orchid Pharma Limited based on total assets are shown below.

Company	Country	Total Assets
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Shanghai Haoyuan Chemexpress Co. Ltd. A SHG:688131	China	CN¥6.49 Billion
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	China	CN¥4.44 Billion
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	China	CN¥7.28 Billion
Celltrion Pharm Inc KQ:068760	Korea	₩745.80 Billion
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	China	CN¥1.54 Billion
Heilongjiang ZBD Pharmaceutical Co Ltd SHG:603567	China	CN¥11.80 Billion
Zhejiang Anglikang Pharmaceutical Co Ltd Class A SHE:002940	China	CN¥3.12 Billion

Orchid Pharma Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.45	2.83	3.87
Quick Ratio	1.53	1.68	2.79
Cash Ratio	0.00	0.00	0.00
Working Capital	Rs4.05 Billion	Rs5.22 Billion	Rs4.08 Billion

Orchid Pharma Limited - Advanced Valuation Insights

This section examines the relationship between Orchid Pharma Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	3.33
Latest Market Cap to Assets Ratio	0.03
Asset Growth Rate (YoY)	13.2%
Total Assets	Rs19.11 Billion
Market Capitalization	$541.13 Million USD

Valuation Analysis

Below Book Valuation: The market values Orchid Pharma Limited's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Orchid Pharma Limited's assets grew by 13.2% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Orchid Pharma Limited (2004–2026)

The table below shows the annual total assets of Orchid Pharma Limited from 2004 to 2026.

Year	Total Assets	Change
2026-03-31	Rs19.11 Billion ≈ $206.66 Million	+13.21%
2025-03-31	Rs16.88 Billion ≈ $182.54 Million	+8.63%
2024-03-31	Rs15.54 Billion ≈ $168.05 Million	+26.83%
2023-03-31	Rs12.25 Billion ≈ $132.50 Million	+10.32%
2022-03-31	Rs11.11 Billion ≈ $120.10 Million	-10.24%
2021-03-31	Rs12.37 Billion ≈ $133.80 Million	-15.25%
2020-03-31	Rs14.60 Billion ≈ $157.88 Million	-52.55%
2019-03-31	Rs30.77 Billion ≈ $332.77 Million	-1.55%
2018-03-31	Rs31.25 Billion ≈ $338.00 Million	-4.00%
2017-03-31	Rs32.56 Billion ≈ $352.08 Million	-15.70%
2016-03-31	Rs38.62 Billion ≈ $417.67 Million	-4.91%
2015-03-31	Rs40.61 Billion ≈ $439.22 Million	-12.68%
2013-03-31	Rs46.51 Billion ≈ $502.99 Million	+16.67%
2012-03-31	Rs39.86 Billion ≈ $431.11 Million	-2.07%
2011-03-31	Rs40.71 Billion ≈ $440.21 Million	+7.87%
2010-03-31	Rs37.74 Billion ≈ $408.10 Million	-10.87%
2009-03-31	Rs42.34 Billion ≈ $457.89 Million	+21.52%
2008-03-31	Rs34.84 Billion ≈ $376.81 Million	+20.52%
2007-03-31	Rs28.91 Billion ≈ $312.65 Million	+33.32%
2006-03-31	Rs21.69 Billion ≈ $234.52 Million	+19.64%
2005-03-31	Rs18.12 Billion ≈ $196.01 Million	+26.94%
2004-03-31	Rs14.28 Billion ≈ $154.41 Million	--

About Orchid Pharma Limited

NSE:ORCHPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$541.13 Million

Rs50.04 Billion INR

Market Cap Rank

#11639 Global

#586 in India

Share Price

Rs986.55

Change (1 day)

-1.37%

52-Week Range

Rs482.45 - Rs1101.40

All Time High

Rs2527.90